Concepedia

Zilong Xu

ZX

5

Publications

219

Citations

5

H-Index

2019

Active since

Affiliations

Xiamen University(Current)

Zhongshan Hospital of Xiamen University

Zilong Xu is an author at Xiamen University specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2019–2024

5

Publications

5

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Fei Ju, Yong Luo, Chaolong Lin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 66 citations · Full text

, , +18

Intratumoral Delivery of a PD-1–Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

Chaolong Lin, Wenfeng Ren, Yong Luo et al. · Cancer Immunology Research · 2020 · 59 citations · Full text

Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1

Zilong Xu, Yating Chang, Fei Ju et al. · Nature Communications · 2024 · 53 citations · Full text

Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma

Yong Luo, Chaolong Lin, Wenfeng Ren et al. · Molecular Therapy — Oncolytics · 2019 · 30 citations · Full text

, , +7

A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D

Rui Tian, Fei Ju, Mengqin Yu et al. · Antiviral Research · 2022 · 11 citations

, , +11

Rows per page

1–5 of 5